Zevra Therapeutics rises amid takeover speculation

Zevra Therapeutics rises amid takeover speculation
Zevra Therapeutics gains amid takeover speculation
#earnings after the close https://t.co/lObOE0dgsr $NU $RUM $INVO $GBNH $GOEV $NVTS $BEEM $ABST $SMTI $XWEL $CSSE $XP $DFLI $QIPT $CRKN $CARA $IZEA $DAC $PPSI $XGN $PX $KULR $SSKN $DUOT $ASTS $MEDS $JHX $AREC $MDWT $OPGN $ONTX $GMDA $EGLX $SNAX $QRHC $FLNT $SLGG $ZVRA $SUNL… https://t.co/YGO6MAAuFy
592.92MUSD
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US4884452065
CUSIP
-
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
4.99
PEG Ratio
10.67
Book Value
2.72
Dividend Share
-
Dividend Yield
-
Earnings Share
2.01
Wall Street Target Price
23.00
EPS Estimate Current Year
1.17
EPS Estimate Next Year
1.92
EPS Estimate Current Quarter
0.0838
EPS Estimate Next Quarter
0.1088
Most Recent Quarter
-
Revenue TTM
122,289,000
Gross Profit TTM
105,255,000
EBITDA
12,734,000
Profit Margin
101.58%
Return On Assets TTM
2.76%
Return On Equity TTM
100.65%
Revenue Per Share TTM
2.169
Qtly Revenue Growth YOY
77.50%
Diluted Eps TTM
2.01
Qtly Earnings Growth YOY
0.00%
Trailing PE
4.99
Forward PE
9
Price Sales TTM
4.8486
Price Book MRQ
2.8796
Enterprise Value Revenue
3
Enterprise Value EBITDA
2
310.25
1.88%297.45
1.40%803.19
0.00%638.88
-10.36%70.00
-4.83%270.35
-4.22%434.52
-3.57%806.46
-1.86%17.65
-1.12%139.99
-0.67%